참고문헌
- Amakiri N, Kubosumi A, Tran J, Reddy PH. Amyloid Beta and MicroRNAs in Alzheimer's Disease. Front Neurosci. 2019. 3: 430.
- Angelucci F, Cechova K, Valis M, Kuca K, Zhang B, Hort J. MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents? Front Pharmacol. 2019. 10: 665. https://doi.org/10.3389/fphar.2019.00665
- Athanasopoulos D, Karagiannis G, Tsolaki M. Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics. Adv Nutr. 2016. 7: 917-927. https://doi.org/10.3945/an.116.012229
- Auso E, Gomez-vicente V, Esquiva G. Biomarkers for Alzheimer's Disease Early Diagnosis. J Pers Med. 2020. 10: 114. https://doi.org/10.3390/jpm10030114
- Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020. 25: 5789. https://doi.org/10.3390/molecules25245789
- Canepa E, Fossati S. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease. Front Neurol. 2021. 11: 573324. https://doi.org/10.3389/fneur.2020.573324
- Cheignon C, Tomas M, Bonnefont-rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol. 2018. 14: 450-464. https://doi.org/10.1016/j.redox.2017.10.014
- Chen F, Chen H, Jia Y, Lu H, Tan Q, Zhou X. miR-149-5p inhibition reduces Alzheimer's disease β-amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8. Exp Ther Med. 2020. 20: 88.
- Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018. 14: 399-415. https://doi.org/10.1038/s41582-018-0013-z
- Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer's disease drug development pipeline: 2020. Alzheimers Dement. 2020. 6: e12050.
- Deng Y, Zhang J, Ma GMa G et al. miR-132 improves the cognitive function of rats with Alzheimer's disease by inhibiting the MAPK1 signal pathway. Exp Ther Med. 2020. 20: 159. https://doi.org/10.3892/etm.2020.9288
- Eyileten C, Sharif L, Wicik ZWicik Z et al. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke. Mol Neurobiol. 2021. 58: 329-347. https://doi.org/10.1007/s12035-020-02101-2
- FracassI A, MarcattI M, Zolochevska OZolochevska O et al. Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer's Neuropathology. J Neurosci. 2021. 41: 538-554. https://doi.org/10.1523/JNEUROSCI.0295-20.2020
- Ghini F, Rubolino C, Climent M, Simeone I, Marzi MJ, Nicassio F. Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation. Nat Commun. 2018. 9: 3119. https://doi.org/10.1038/s41467-018-05182-9
- Goedert M. Tau filaments in neurodegenerative diseases. FEBS Lett. 2018. 592: 2383-2391. https://doi.org/10.1002/1873-3468.13108
- Guan P, Cao L, Wang P. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau. Int J Mol Sci. 2021. 22: 5900. https://doi.org/10.3390/ijms22115900
- Gugliandolo A, Chiricosta L, BoccardI V, Mecocci P, Bramanti P, Mazzon E. MicroRNAs Modulate the Pathogenesis of Alzheimer's Disease: An In Silico Analysis in the Human Brain. Genes. 2020. 11: 983. https://doi.org/10.3390/genes11090983
- Guo Y, Wu Y, Li N, Wang Z. Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53. Exp Mol Pathol. 2021. 118: 104587. https://doi.org/10.1016/j.yexmp.2020.104587
- Hamano T, Enomoto S, Shirafuji NShirafuji N et al. Autophagy and Tau Protein. Int J Mol Sci. 2021. 22: 7475. https://doi.org/10.3390/ijms22147475
- Hara N, Kikuchi M, Miyashita AMiyashita A et al. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease. Acta Neuropathol Commun. 2017. 5: 10. https://doi.org/10.1186/s40478-017-0414-z
- Huang Y, Mucke L. Alzheimer Mechanisms and Therapeutic Strategies. Cell. 2012. 148: 1204-1222. https://doi.org/10.1016/j.cell.2012.02.040
- Improta-Caria AC, Nonaka CKV, Cavalcante BRRCavalcante BRR et al. Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease. Int J Mol Sci. 2020. 21: 4977. https://doi.org/10.3390/ijms21144977
- Jaber VR, Zhao Y, Sharfman NM, Li W, Lukiw WJ. Addressing Alzheimer's Disease (AD) Neuropathology Using Anti-microRNA (AM) Strategies. Mol Neurobiol. 2019. 56: 8101-8108. https://doi.org/10.1007/s12035-019-1632-0
- Jiang L, Dong H, Cao H, Ji X, Luan S, Liu J. Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease. Med Sci Monit. 2019. 25: 3329-3335. https://doi.org/10.12659/msm.914027
- Kent SA, Spires-Jones TL, Durrant CS. The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics. Acta Neuropathological. 2020. 140: 417-447. https://doi.org/10.1007/s00401-020-02196-w
- Kim E, Otgontenger U, Jamsranjav A, Kim SS. Deleterious Alteration of Glia in the Brain of Alzheimer's Disease. Int J Mol Sci. 2020. 21: 6676. https://doi.org/10.3390/ijms21186676
- Koh HS, Lee SJ, Lee HJLee HJ et al. Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression. Int J Mol Sci. 2021. 22: 13136. https://doi.org/10.3390/ijms222313136
- Kumar S, Reddy AP, Yin XYin X et al. Novel MicroRNA-455-3p and its Protective Effects Against Abnormal APP Processing and Amyloid Beta Toxicity in Alzheimer's Disease. Biochim Biophys Acta Mol Basis Dis. 2019. 1865: 2428-2440. https://doi.org/10.1016/j.bbadis.2019.06.006
- Kumar S, Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? Biochim Biophys Acta. 2016. 1862: 1617-1627. https://doi.org/10.1016/j.bbadis.2016.06.001
- Kumar S, Reddy PH. MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update. Front Aging Neurosci. 2018. 10: 41. https://doi.org/10.3389/fnagi.2018.00041
- Li J, Salvador AM, Li GLi G et al. Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling. Circ Res. 2021. 128: e1-e23.
- Liu X, Wang H, Bei J, Zha J, Jiang G, Liu X. The protective role of miR-132 targeting HMGA2 through the PI3K/AKT pathway in mice with Alzheimer's disease. Am J Transl Res. 2021. 13: 4632-4643.
- Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018. 141: 1202-1207. https://doi.org/10.1016/j.jaci.2017.08.034
- Lukiw WJ, Vergallo A, Lista S, Hampel H, Zhao Y. Biomarkers for Alzheimer's Disease (AD) and the Application of Precision Medicine. J Pers Med. 2020. 10: 138. https://doi.org/10.3390/jpm10030138
- Madadi S, Schwarzenbach H, Saidijam M, Mahjub R, Soleimani M. Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease. Cell Biosci. 2019. 9: 91. https://doi.org/10.1186/s13578-019-0354-3
- Manna I, De Benedittis S, Quattrone A, Maisano D, Iaccino E, Quattrone A. Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease. Pharmaceuticals. 2020. 13: 243. https://doi.org/10.3390/ph13090243
- Mantzavinos V, Alexiou A. Biomarkers for Alzheimer's Disease Diagnosis. Curr Alzheimer Res. 2017. 14: 1149-1154.
- Michalicova A, Majerova P, Kovac A. Tau Protein and Its Role in Blood-Brain Barrier Dysfunction. Front Mol Neurosci. 2020. 13: 570045. https://doi.org/10.3389/fnmol.2020.570045
- Nasaruddin ML, Syarifah ASAH, Kamaruzzaman MA. Studying the Relationship of Intermittent Fasting and β-Amyloid in Animal Model of Alzheimer's Disease: A Scoping Review. Nutrients. 2020. 12: 3215. https://doi.org/10.3390/nu12103215
- Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer's disease. Neurosci Lett. 2019. 705: 183-194. https://doi.org/10.1016/j.neulet.2019.04.022
- Prendecki M, Dorszewska J. The role of MicroRNA in the pathogenesis and diagnosis of neurodegenerative diseases. Austin Alzheimers J. Parkinsons Dis. 2014. 1: 10.
- Pirscoveanu DFV, Pirici I, Tudorica VTudorica V et al. Tau protein in neurodegenerative diseases - a review. Rom J Morphol Embryol. 2017. 58: 1141-1150.
- Rabbito A, Dulewicz M, Kulczynska-przybik A, Mroczko B. Biochemical Markers in Alzheimer's Disease. Int J Mol Sci. 2020. 21: 1989. https://doi.org/10.3390/ijms21061989
- Rasgado LAV, Urbieta AT, Jimenez JMM. Affected albumin endocytosis as a new neurotoxicity mechanism of amyloid beta. AIMS neurosci. 2020. 7: 344-359. https://doi.org/10.3934/Neuroscience.2020021
- Santa-Maria I, Alaniz ME, Renwick NRenwick N et al. Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest. 2015. 125: 681-686. https://doi.org/10.1172/JCI78421
- Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021. 20: 68-80. https://doi.org/10.1016/s1474-4422(20)30412-9
- Sheinerman KS, Toledo JB, Tsivinsky VGTsivinsky VG et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimer's Res Ther. 2017. 9: 89. https://doi.org/10.1186/s13195-017-0316-0
- Shi L, Zhang R, Li TLi T et al. Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway. Aging. 2020. 13: 4590-4604.
- Soares Martins T, Trindade D, Vaz MVaz M et al. Diagnostic and therapeutic potential of exosomes in Alzheimer's disease. J Neurochem. 2021. 156: 162-181. https://doi.org/10.1111/jnc.15112
- Swarbrick S, Wragg N, Ghosh S, Stolzing A. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease. Mol Neurobiol. 2019. 56: 6156-6167. https://doi.org/10.1007/s12035-019-1500-y
- Van Giau V, An SS. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease. J Neurol Sci. 2016. 360: 141-152. https://doi.org/10.1016/j.jns.2015.12.005
- Vergallo A, Lista S, Zhao YZhao Y et al. MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints. Transl Psychiatry. 2021. 11: 78. https://doi.org/10.1038/s41398-020-01184-8
- Wang M, Qin L, Tang B. MicroRNAs in Alzheimer's Disease. Front Genet. 2019. 10: 153. https://doi.org/10.3389/fgene.2019.00153
- Wang X, Zhou Y, Gao QGao Q et al. The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases. Oxid Med Cell Longev. 2020. 3232869.
- Wei W, Wang ZY, Ma LN, Zhang TT, Cao Y, Li H. MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers. Front Mol Neurosci. 2020. 13: 160. https://doi.org/10.3389/fnmol.2020.00160
- Weller J, Budson A. Current understanding of Alzheimer's disease diagnosis and treatment. F1000 Res. 2018. 7: Faculty Rev-1161.
- Wilkins HM, Swerdlow RH. Amyloid precursor protein processing and bioenergetics. Brain Res Bull. 2017. 133: 71-79. https://doi.org/10.1016/j.brainresbull.2016.08.009
- Wu HZY, Thalamuthu A, Cheng LCheng L et al. Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer's disease and controls. Alzheimer's Res Ther. 2020. 12: 59. https://doi.org/10.1186/s13195-020-00627-0
- Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers. Biomed Environ Sci. 2018. 31: 87-96.
- Yu L, Li H, Liu WLiu W et al. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Mol Genet Genomic Med. 2021. 9: e1548.
- Zetterberg H, Burnham SC. Blood-based molecular biomarkers for Alzheimer's disease. Mol Brain. 2019. 12: 26. https://doi.org/10.1186/s13041-019-0448-1
- Zhao Y, Hampel H, Vergallo A, Lista S, Lukiw WJ. Biomarkers for Alzheimer's Disease (AD) and the Application of Precision Medicine. J Pers Med. 2020. 10: 138. https://doi.org/10.3390/jpm10030138
- Zhao Y, Jaber V, Alexandrov PNAlexandrov PN et al. microRNA-Based Biomarkers in Alzheimer's Disease. Front Neurosci. 2020. 14: 585432. https://doi.org/10.3389/fnins.2020.585432
- Zhou Q, Luo L, Wang X, Li X. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism. Biosci Rep. 2019. 39: BSR20182485. https://doi.org/10.1042/BSR20182485